Biologic grafts for cystocele repair: does concomitant midline fascial plication improve surgical outcomes?

Int Urogynecol J. 2011 Aug;22(8):985-90. doi: 10.1007/s00192-011-1408-1. Epub 2011 Apr 12.

Abstract

Introduction and hypothesis: This study aims to compare the efficacy of porcine graft-augmented anterior prolapse repair with and without underlying pubocervical fascia plication.

Methods: Women with symptomatic anterior prolapse who underwent transvaginal repair, using biologic graft via transobturator approach, were retrospectively studied. An initial cohort had the graft placed without fascial plication. A second cohort had graft placement as an overlay to fascial plication.

Results: Between March 2005 and September 2008, 65 subjects underwent anterior repair with biologic graft; 35 without fascial plication and 30 as an overlay to plication. At 6 months follow-up, anatomic recurrence (Ba>/= -1) was significantly higher in the non-plicated group (18/35, 51%) compared with the plicated group (2/30, 7%) p < 0.01. Five (5/35, 14%) in the non-plicated group compared with none (0/30) in the plicated group underwent further treatment (p = 0.06).

Conclusions: When using a non-crosslinked biologic graft for repair of anterior vaginal prolapse, we recommend the addition of concomitant midline fascial plication to enhance anatomic outcome.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Bioprosthesis*
  • Cystocele / surgery*
  • Fasciotomy*
  • Female
  • Humans
  • Middle Aged
  • Patient Satisfaction
  • Recurrence
  • Retrospective Studies
  • Sexual Behavior
  • Treatment Outcome